Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2025-12-24 @ 4:05 PM
NCT ID:
NCT01328366
Eligibility Criteria:
Inclusion Criteria:
* Participants were eligible for adalimumab as determined by the National Institute for Health and Clinical Excellence (NICE) criteria
* Participants had severe psoriasis as defined by a Psoriasis Area Severity Index (PASI) of 10 or more and a Dermatology Life Quality Index (DLQI) of more than 10
* Participant's psoriasis did not respond to standard systemic therapies, to include: ciclosporin, methotrexate, and psoralen and long-wave ultraviolet radiation; or the participant was intolerant of or had a contraindication to these treatments
Exclusion Criteria:
* Participants were previously treated with another biologic therapy
* Participants were unable or unwilling to complete the study questionnaires
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01328366
Study Brief:
Protocol Section:
NCT01328366